Ignite Creation Date:
2024-05-06 @ 9:52 AM
Last Modification Date:
2024-10-26 @ 12:20 PM
Study NCT ID:
NCT03090984
Status:
COMPLETED
Last Update Posted:
2017-08-15
First Post:
2017-02-10
Brief Title:
Evaluation of Contact Phase Activation During Hemodialysis
Sponsor:
Universitair Ziekenhuis Brussel
Organization:
Universitair Ziekenhuis Brussel
Study Overview
Official Title:
Evaluation of Contact Phase Activation During Hemodialysis Using Different Dialysis Membranes a Prospective Randomized Crossover Study
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
c-phact
Brief Summary:
Every patient included in the study will undergo 3 standardised hemodialysis treatments each using a different dialysis membrane PMMA PS AN69ST The order of the membranes used will be randomized
During each conventional and standardised hemodialysis treatment 6 blood samples will be taken at different time points T0 T5 T15 T30 T90 T240 to evaluate coagulation activation TAT PF12 d-dimers TF and more specifically activation of the contact phase pathway of coagulation kallikrein fXIa fXIIa
During each conventional and standardised hemodialysis treatment 6 blood samples will be taken at different time points T0 T5 T15 T30 T90 T240 to evaluate coagulation activation TAT PF12 d-dimers TF and more specifically activation of the contact phase pathway of coagulation kallikrein fXIa fXIIa
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None